Epidural Study of Patients With Chronic Lower Back Pain
CompletedNot applicableNCT00887003
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
Brief summary (from the registry)
The purpose of this study is to examine 4 different epidural dosing regimes of local anaesthetic solution in a series of 3 epidural injections over a period of 12 months to determine the optimum dose of anaesthetic solution for pain relief and to determine the nature of any adverse events by measuring anxiety and depression, functionality and any side effects of the medication.
Study details
- Official title
- Effects of Volume and Dose of Local Anaesthetic Solution in Epidural Steroidal Injections for Patients With Chronic Lower Back Pain
- Conditions
- Interventions
- Drug: Bupivacaine
- Drug: Bupivacaine
- Drug: Bupivacaine
- Drug: Bupivacaine
- Drug: Depo-Medrol
- Sponsor
- McMaster University
- Collaborators
- St. Joseph's Healthcare Hamilton
- Start date
- 2005-05
- Primary completion
- 2011-08
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Canada
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * 18-75 years old * lower back pains \> 6 months * no lumbar epidural in past 6 months * no previous back surgery * written informed consent to participate in study Exclusion Criteria: * acute lower back pain * pregnancy * significant psychiatric disease * local or systemic infection * coagulopathy/anticoagulant therapy * bleeding diathesis * presently enrolled in another study
Canadian sites (1)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00887003